EUVIMEDEUVIMED entdecken
Crossref

Inhibitory effect of liriopesides B in combination with gemcitabine on human pancreatic cancer cells

Peng Hong, Mengshuo Wu, Xingchuan Wei, Xuetao Xu, Panpan Wu, Lishe Gan, Rihui Wu, Jingwei Jin, Kun Zhang, Dongli Li, Min Chen, Wingleung Wong und 2 weitere

Bioorganic Chemistry · 2024-01 · 142 · 106937

DOI: 10.1016/j.bioorg.2023.106937 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2024-01. Verfasst von Peng Hong und 13 weiteren Autor:innen. Beteiligte Einrichtung: School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China. Hauptthemen laut MEDLINE: Gemcitabine, Pancreatic Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GemcitabinePancreatic NeoplasmsHumansDeoxycytidineCell Line, TumorNF-kappa BApoptosisCell ProliferationHeterocyclic Compounds, 4 or More RingsSpiro Compounds

Stichwörter der Autor:innen

ApoptosisGemcitabineNF-κBPancreatic cancerliriopesides B

Substanzen

GemcitabineDeoxycytidineNF-kappa Bliriopesides BHeterocyclic Compounds, 4 or More RingsSpiro Compounds

Autor:innen und Institutionen

  • School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China.
  • School of Chemistry and Chemical Engineering, Guangzhou University, Guangzhou 510006, China.
  • School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China; International Healthcare Innovation Institute (Jiangmen), Jiangmen 529020, China.
  • School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China; International Healthcare Innovation Institute (Jiangmen), Jiangmen 529020, China; Guangdong Provincial Key Laboratory of Large Animal…
  • Neher's Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau 999078, China.

Zitieren

APA

Hong, P., Wu, M., Wei, X., Xu, X., Wu, P., Gan, L., Wu, R., Jin, J., Zhang, K., Li, D., Chen, M., Wong, W., Liu, W., & Zheng, X. (2024). Inhibitory effect of liriopesides B in combination with gemcitabine on human pancreatic cancer cells. Bioorganic Chemistry, 142, 106937. https://doi.org/10.1016/j.bioorg.2023.106937

Vancouver

Hong P, Wu M, Wei X, Xu X, Wu P, Gan L, et al. Inhibitory effect of liriopesides B in combination with gemcitabine on human pancreatic cancer cells. Bioorganic Chemistry. 2024;142:106937. doi:10.1016/j.bioorg.2023.106937

BibTeX
@article{Hong2024,
  author = {Hong, Peng and Wu, Mengshuo and Wei, Xingchuan and Xu, Xuetao and Wu, Panpan and Gan, Lishe and Wu, Rihui and Jin, Jingwei and Zhang, Kun and Li, Dongli and Chen, Min and Wong, Wingleung and Liu, Wenfeng and Zheng, Xi},
  title = {Inhibitory effect of liriopesides B in combination with gemcitabine on human pancreatic cancer cells},
  journal = {Bioorganic Chemistry},
  year = {2024},
  volume = {142},
  pages = {106937},
  doi = {10.1016/j.bioorg.2023.106937}
}
Kostenlos starten →